Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Redrawing the Lines
Abstract
Share and Cite
Matutino, A.; Joy, A.A.; Brezden-Masley, C.; Chia, S.; Verma, S. Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Redrawing the Lines. Curr. Oncol. 2018, 25, 131-141. https://0-doi-org.brum.beds.ac.uk/10.3747/co.25.4000
Matutino A, Joy AA, Brezden-Masley C, Chia S, Verma S. Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Redrawing the Lines. Current Oncology. 2018; 25(s1):131-141. https://0-doi-org.brum.beds.ac.uk/10.3747/co.25.4000
Chicago/Turabian StyleMatutino, A., A.A. Joy, C. Brezden-Masley, S. Chia, and S. Verma. 2018. "Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Redrawing the Lines" Current Oncology 25, no. s1: 131-141. https://0-doi-org.brum.beds.ac.uk/10.3747/co.25.4000